The New Era of Alzheimer’s Disease: Can We Diagnose Earlier?

{
  "id": "PP1149868",
  "track": "Health",
  "focus_area": null,
  "category": "Panel",
  "event_id": "PP1149868",
  "event_type": "panel",
  "format": "Panel",
  "genre": null,
  "subgenre": null,
  "name": "The New Era of Alzheimer’s Disease: Can We Diagnose Earlier?",
  "presented_by": null,
  "publish_at": "2026-02-20T12:11:00.000-06:00",
  "reservable": true,
  "reservable_id": "PP1149868",
  "reserved": false,
  "date": "2026-03-16",
  "end_time": "2026-03-16T11:00:00.000-05:00",
  "start_time": "2026-03-16T10:00:00.000-05:00",
  "message": null,
  "image": null,
  "credentials": [
    {
      "name": "Platinum Badge",
      "type": "platinum"
    },
    {
      "name": "Innovation Badge",
      "type": "innovation"
    }
  ],
  "contributors": [
    {
      "id": 109221,
      "company": "Eli Lilly and Company",
      "credential_types": [
        "innovation"
      ],
      "entity_id": 2284032,
      "name": "Jennifer Oleksiw",
      "speaker_types": [
        "Speaker"
      ],
      "title": "Group Vice President, U.s. Neuroscience And Global Commercial Innovation Officer",
      "image": {
        "alt_text": "Jennifer Oleksiw",
        "credit": null,
        "url": "https://images.sxsw.com/1dSdjARri2By4keEXjwx_Wc9BvU=/0x0:337x337/600x600/images.sxsw.com/48/c3619ab4-52d3-48c5-b3df-9554015af84a/pcid-23"
      },
      "speaker_type": "Speaker",
      "details": "Jennifer Oleksiw is Group Vice President, U.S. Neuroscience and Global Commercial Innovation Officer at Eli Lilly and Company, where she leads the U.S. Neuroscience commercial organization and drives innovation across global commercial capabilities. Her work focuses on accelerating patient access to medicines and advancing earlier diagnosis and treatment in Alzheimer’s disease. With more than 25 years of experience across technology, operations, and customer engagement, she brings a systems‑level approach to commercial transformation. She joined Lilly in 2000 from Ernst & Young and has held leadership roles spanning IT, marketing, and medical functions. Jennifer serves on the Open Evidence Advisory Board and holds a BS from Indiana University and an MBA from Northwestern University’s Kellogg School of Management.",
      "links": {},
      "type": "person"
    },
    {
      "id": 106342,
      "company": "CBS News",
      "credential_types": [
        "innovation"
      ],
      "entity_id": 2278002,
      "name": "Natalie Morales",
      "speaker_types": [
        "Speaker"
      ],
      "title": "CBS News Correspondent and 48 Hours Contributor",
      "image": {
        "alt_text": "Natalie Morales",
        "credit": null,
        "url": "https://images.sxsw.com/Ms5Q6qIrmEo2_Zo2n93yHFaSoRM=/0x0:600x600/600x600/images.sxsw.com/48/90c4cce8-e09c-42de-ab6d-01117c1e6995/pcid-1656396"
      },
      "speaker_type": "Speaker",
      "details": null,
      "links": {},
      "type": "person"
    },
    {
      "id": 96534,
      "company": "Weill Cornell Medicine/New York-Presbyterian",
      "credential_types": [
        "innovation"
      ],
      "entity_id": 2260002,
      "name": "Dr. Richard S. Isaacson",
      "speaker_types": [
        "Speaker"
      ],
      "title": "Director of Research, Institute for Neurodegenerative Diseases",
      "image": {
        "alt_text": "Dr. Richard S. Isaacson",
        "credit": "",
        "url": "https://images.sxsw.com/QnDRZhL7LFW5f8kyeeOXtalAI6M=/33x0:213x180/600x600/images.sxsw.com/48/b09f1b32-94f8-4a2e-873b-3f324b474488/pcid-1645868"
      },
      "speaker_type": "Speaker",
      "details": "Dr. Isaacson is a neurologist specializing in the prevention and treatment of Alzheimer’s disease. He is the founder and former director of the world’s first Alzheimer’s Prevention Clinic at Weill Cornell Medicine/NewYork-Presbyterian, where he also served as assistant dean of faculty development and associate professor of neurology. Dr. Isaacson is a leader in precision-medicine approaches to Alzheimer’s risk reduction and has served as principal investigator for multiple research initiatives focused on individualized, risk reduction care. \r\rHis recently lead an NIH-funded clinical trial showing the ability of a free online tool to reduce Alzheimer's risk by 6% in six months (RetainYourBrain.com) and aims to democratize access to blood-biomarker testing for brain health via an at-home, lower-cost \"cholesterol test for the brain\" to both assess risk and evaluate response to risk reduction therapies.",
      "links": {},
      "type": "person"
    },
    {
      "id": 96533,
      "company": "NBC News/MSNOW",
      "credential_types": [
        "innovation"
      ],
      "entity_id": 2260001,
      "name": "Richard Lui",
      "speaker_types": [
        "Speaker"
      ],
      "title": "News Anchor And Filmmaker",
      "image": {
        "alt_text": "Richard Lui",
        "credit": null,
        "url": "https://images.sxsw.com/FyUzpFRZKwWdL5bhlEeRIPW49K8=/0x0:600x600/600x600/images.sxsw.com/48/614df1a8-55c5-4ac6-a06b-19f11f49a8e9/pcid-1645857"
      },
      "speaker_type": "Speaker",
      "details": "Richard Lui is a Peabody and Murrow award-winning journalist with over 30 years of experience in media, technology, and business. After two decades at NBCU News Group and CNN Worldwide, he remains one of the most dependable, authoritative anchors in journalism today. Outside of work, Richard has traveled every other week for 10 years from New York to California to care for his father and mother, who have faced Alzheimer’s and/or dementia. This journey led him to direct two Oscar-qualifying movies on caregiving and is now in production on two films, a third on elected officials who are caregiving (To the Moon) and a second on the inventor of the AIDS/HIV treatment that's saved more than 32 million lives (Dr. Hope). Drawing on his years at Citibank and as a patented fintech entrepreneur, he actively invests professionally and personally in the care and brain economy as Principal, Care & Data Science, CAREGenome and Chief Impact Officer, Caregiving Moonshot (Startup Health). Among those efforts, he serves as an AARP Caregiving Champion and an Alzheimer’s Association Celebrity Champion.",
      "links": {},
      "type": "person"
    }
  ],
  "venue": {
    "accessible": false,
    "age_policy": null,
    "floor": null,
    "id": "V0573",
    "indoor_outdoor": "INDOOR",
    "mixhalo_url": "https://translate.mixhalo.rocks/430?venue_id=430&partner=true",
    "name": "Salon FGH",
    "parent_id": "V0403",
    "parent_venue_name": "JW Marriott",
    "venue_entry_info": null,
    "formats": null,
    "location": {
      "address": "110 E 2nd St.",
      "lat_lon": [
        30.2645713,
        -97.743198
      ],
      "city": "Austin",
      "postal_code": "78701",
      "state": "TX",
      "name": "JW Marriott"
    },
    "root": {
      "id": "V0403",
      "name": "JW Marriott",
      "mixhalo_url": null
    },
    "events": "[omitted 5 venue events]"
  },
  "description": "Imagine a world where Alzheimer's disease can be detected before memory fades. Would you want to know if you were at risk? For most Americans surveyed, the answer is yes: nearly 4 in 5 say they would want to know before it impacts their lives. This session explores emerging tools to diagnose Alzheimer's disease at the earliest stages, the challenges ahead, and what early awareness means for people, caregivers, and healthcare systems preparing for new approaches to proactive brain health.  ",
  "experience_level": "Intermediate",
  "audio_url": null,
  "accessibility": [
    "Closed captioned"
  ],
  "accessible_venue": false,
  "add_bcl_url": false,
  "add_slido": false,
  "after_midnight": null,
  "age_policy": null,
  "american_sign_language": false,
  "apple_url": null,
  "audio_description": false,
  "caption_url": null,
  "captioned_qa": false,
  "closed_captioned": true,
  "cpe_credit": false,
  "event_status": "none",
  "has_subtitles": false,
  "hash_tags": [],
  "high_sensory_experience": false,
  "live": false,
  "long_description": "Imagine a world where Alzheimer's disease can be detected before memory fades. Would you want to know if you were at risk? For most Americans surveyed, the answer is yes: nearly 4 in 5 say they would want to know before it impacts their lives. This session explores emerging tools to diagnose Alzheimer's disease at the earliest stages, the challenges ahead, and what early awareness means for people, caregivers, and healthcare systems preparing for new approaches to proactive brain health.  ",
  "meeting_url": null,
  "meeting_url_live": false,
  "mentorly_url": null,
  "mobile_audio_url": null,
  "open_captioned": false,
  "playlist_tag": null,
  "rebroadcast": false,
  "recommended_ids": [],
  "search_conversions": null,
  "short_program": false,
  "slido_url": null,
  "sort": "NEW ERA OF ALZHEIMER?S DISEASE: CAN WE DIAGNOSE EARLIER?",
  "source": "Official",
  "squad_up_url": null,
  "stream_embed": null,
  "stream_id": null,
  "stream_url": null,
  "strobe_warning": false,
  "subdiscipline": null,
  "summit": null,
  "summit_display_name": null,
  "tags": [],
  "talent_attending": null,
  "title_only": false,
  "track_display_name": "Health track sponsored by Eli Lilly",
  "trailer_id": null,
  "trailer_url": null,
  "video_on_demand": null,
  "vimeo_id": null,
  "vod": false,
  "xr_project_type": null,
  "youtube_id": null,
  "related_events": [],
  "related_sales_client": null
}